arBtrage CAPITALIZING MARKETS checking… Sign in

Replimune Group, Inc.

REPL Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$9.47
▼ -4.0% Today
as of Jun 7, 06:45 ET
Last 30 days +268.48% Apr 28 → Jun 05
$1.77 $3.98 $6.18 $8.38 $10.59 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$9.98
High
$10.46
Low
$9.39
Volume
$5M
Avg Vol
$6M
Mkt Cap
$815M
P/E (TTM)
Beta
52w High
$13.24
52w Low
$1.50
Div Yield
Shares Out
$80M

Overview

52-week range
$1.50
$13
68% of range
Avg surprise (last 1)
-9.3%
Avg reaction (last 1)
+3.5%
100% positive
Latest IV / EM
153%
EM ±14.3% · $10 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.95$-0.88$-0.81$-0.75$-0.68 Actual $-0.75Actual $-0.90Actual $-0.77Actual $-0.78Actual $-0.68Actual $-0.79Actual $-0.82Est $-0.75Actual $-0.95Actual $-0.90Actual $-0.77 JunSepDecJunSepDecMar/2025JunSepDec
Revenue vs Net Income Revenue Net income
$-87M$-79M$-71M$-63M$-56M Jun 24Sep 24Dec 24Jun 25Sep 25Dec 25

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Dec 31, 2025Dec 2025 $-0.77 financials
Tue Sep 30, 2025Sep 2025 $-0.90 financials
Mon Jun 30, 2025Jun 2025 $-0.95 financials
Thu May 22, 2025Mar/2025 $-0.82 $-0.75 -9.3% +3.5% earnings
Tue Dec 31, 2024Dec 2024 $-0.79 financials
Mon Sep 30, 2024Sep 2024 $-0.68 financials
Sun Jun 30, 2024Jun 2024 $-0.78 financials
Sun Dec 31, 2023Dec 2023 $-0.77 financials
Sat Sep 30, 2023Sep 2023 $-0.90 financials
Fri Jun 30, 2023Jun 2023 $-0.75 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Jun 11, 2026Mar/2026OTHER -$0.73-$0.82 +11.0%

Financials

Income statement (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
Cost of revenue
Gross profit
Operating income$-72M$-84M$-90M$-66M$-59M$-57M
Net income$-71M$-83M$-87M$-66M$-53M$-54M
EPS (diluted)$-0.77$-0.90$-0.95$-0.79$-0.68$-0.78

Balance sheet (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Cash & equivalents$123M$102M$97M$111M$172M$113M$152M$74M
Inventory
Total current assets$280M$334M$413M$496M$548M$443M$480M$434M
Total assets$334M$389M$470M$551M$604M$498M$535M$488M
Long-term debt$48M$47M$47M$46M$46M$46M$45M$45M
Total liabilities$123M$126M$133M$135M$121M$117M$109M$113M
Total equity$211M$263M$337M$416M$482M$381M$426M$375M

Implied volatility — last 90 days

147%150%152%155%157% Jun 07 — IV 153% · EM ±14.3%

Sector peers